Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)

ClinicalTrials.gov ID: NCT05972044

Public ClinicalTrials.gov record NCT05972044. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 6:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of Solriamfetol in Adults With ADHD.

Study identification

NCT ID
NCT05972044
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
516 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Drug
  • Solriamfetol 150 mg Drug
  • Solriamfetol 300 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 5, 2023
Primary completion
Feb 6, 2025
Completion
Mar 13, 2025
Last update posted
Feb 9, 2026

2023 – 2025

United States locations

U.S. sites
42
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
Clinical Research Site Encino California 91316
Clinical Research Site Garden Grove California 92845
Clinical Research Site Newport Beach California 92660
Clinical Research Site Riverside California 92506
Clinical Research Site Santa Ana California 92705
Clinical Research Site Sherman Oaks California 91403
Clinical Research Site Torrance California 90504
Clinical Research Site Walnut Creek California 94596
Clinical Research Site Colorado Springs Colorado 80910
Clinical Research Site Clermont Florida 34711
Clinical Research Site Doral Florida 33122
Clinical Research Site Gainesville Florida 32607
Clinical Research Site Jacksonville Florida 32256
Clinical Research Site Lauderhill Florida 33319
Clinical Research Site Miami Lakes Florida 33016
Clinical Research Site Orlando Florida 32801
Clinical Research Site Marietta Georgia 30060
Clinical Research Site Overland Park Kansas 66210
Clinical Research Site Boston Massachusetts 02131
Clinical Research Site Saint Charles Missouri 63304
Clinical Research Site Lincoln Nebraska 68526
Clinical Research Site Las Vegas Nevada 89102
Clinical Research Site Las Vegas Nevada 89128
Clinical Research Site Berlin New Jersey 08009
Clinical Research Site Cherry Hill New Jersey 08002
Clinical Research Site Princeton New Jersey 08540
Clinical Research Site Mount Kisco New York 10549
Clinical Research Site New York New York 10128
Clinical Research Site Raleigh North Carolina 27609
Clinical Research Site Cincinnati Ohio 45219
Clinical Research Site Kettering Ohio 45439
Clinical Research Site Oklahoma City Oklahoma 73116
Clinical Research Site Media Pennsylvania 19063
Clinical Research Site North Charleston South Carolina 29405
Clinical Research Site Memphis Tennessee 38119
Clinical Research Site Austin Texas 78737
Clinical Research Site Bellaire Texas 77401
Clinical Research Site Dallas Texas 75243
Clinical Research Site Dallas Texas 75251
Clinical Research Site San Antonio Texas 78229
Clinical Research Site Draper Utah 84020
Clinical Research Site Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05972044, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05972044 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →